Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series
Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...
| المؤلفون الرئيسيون: | , , , , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
Taylor & Francis Group
2019-06-01
|
| سلاسل: | CNS Oncology |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.futuremedicine.com/doi/10.2217/cns-2019-0007 |